Exosomes derived from HCC cells induced sorafenib resistance both in vitro and in vivo by activating the HGF/c-Met/Akt signaling pathway and inhibiting sorafenib-induced apoptosis. The gene discussed is AKT1; the disease is hepatocellular carcinoma.